Advanced Therapeutic Technologies

The BSc in Advanced Therapeutic Technologies (ATT) is an innovative science degree that combines biomedical science, biopharmaceutical innovation and emerging healthcare technologies. At RCSI, you will explore the full lifecycle of modern medicines, from drug discovery and development to GMP manufacturing, clinical application and patient care.

The programme incorporates advanced therapeutics and technologies including cell therapy, gene therapy, immunotherapy, precision medicine, genomics, data analytics, computational biology and AI.

Developed in collaboration with industry, the programme enables you to build essential skills such as communication, teamwork, leadership and project management. In semester 2 of Year 3, you will undertake an eight-month placement in industry or research, where you will demonstrate, apply and further develop your technical knowledge, skills and competencies while building your professional network.

Through laboratory-based learning, research experience and international opportunities, you will graduate prepared to drive the next generation of biomedical innovation.

The BSc ATT will prepare you for a wide range of careers across the biopharmaceutical, biotechnology, healthcare and life sciences sectors, as well as research in industry or academia and related fields such as management consultancy.

You will develop expertise in drug discovery, pharmaceutical technology, precision medicine, clinical trials, data analytics, computational biology and research, alongside professional skills including communication, teamwork, leadership and project management.

Through hands-on laboratory training, international research opportunities and an industry or research placement, you will gain practical experience and build your professional network.

Career pathways include research and development, clinical trial design and management, biomanufacturing, bioprocessing, regulatory affairs, cell and gene therapy, GMP manufacturing, data analytics, data science, quality assurance and compliance, connected health, scientific research in industry or academia, management consultancy and healthcare innovation within the global biotech industry and related sectors.

Ireland is one of the world’s leading centres for biopharmaceutical, biotechnology and medical technology innovation, making it an ideal location to study Advanced Therapeutic Technologies.

Home to many of the world’s largest life sciences companies, Ireland offers unique access to the rapidly growing biotech industry and advanced manufacturing sector. At RCSI, you will explore new and emerging applications of cell therapy, gene therapy, immunotherapy, precision medicine, data analytics and computational biology.

Developed with industry partners, the programme combines practical laboratory learning, research experience, international opportunities and an industry or research placement, equipping you with the scientific, digital and professional skills required to shape the future of healthcare.

As a health sciences university, RCSI offers a distinctive approach by combining biomedical science with healthcare innovation, digital technologies and real-world industry engagement.

The Advanced Therapeutic Technologies programme extends beyond the traditional biomedical science curriculum to include new and emerging applications of cell therapy, gene therapy, immunotherapy, precision medicine, data analytics, computational biology and AI in healthcare. Developed in partnership with leading biopharma companies, the programme also prioritises the development of professional skills including communication, teamwork, leadership and project management.

You will benefit from research opportunities, Erasmus and international experiences and an eight-month industry or research placement, ensuring you graduate with both technical expertise and the skills required for a successful career in the biopharma industry and related areas.

As a student on the BSc ATT programme, you will gain hands-on experience using a range of modern laboratory, research and digital technologies.

Training spans both wet-lab and dry-lab environments, providing exposure to genomics, theranostics, computational biology, AI, machine learning, data analytics and precision medicine.

You will develop practical skills relevant to drug discovery, validation, pharmaceutical technology and biomedical innovation while learning techniques used in clinical research and advanced therapeutics.

Through collaboration with the National Institute for Bioprocessing Research and Training (NIBRT), all BSc ATT students receive dedicated training in biopharma manufacturing methods and gain valuable insight into biopharmaceutical production and GMP manufacturing environments used across the global biotech industry.

Yes, therapeutic technologies is in demand as a career. The biopharmaceutical, biotechnology and healthcare innovation sectors are rapidly growing, with strong industry engagement and ongoing investment in research, advanced manufacturing and digital health.

Graduates with expertise in areas such as cell and gene therapy, immunotherapy, precision medicine, data analytics and computational biology are highly sought after by employers in Ireland and internationally. This demand is driven by the expansion of the global biotech industry and the need for professionals with both technical and professional skills to support innovation and growth in these fields.

Graduates of RCSI’s BSc ATT are well positioned for careers with leading employers across the biopharmaceutical, biotechnology, pharmaceutical technology and healthcare sectors, as well as related industries including management consultancy.

Ireland hosts many global life sciences organisations, including Pfizer, Johnson & Johnson, Eli Lilly, Roche, MSD, Amgen, AbbVie, Regeneron, Bristol Myers Squibb, Sanofi and Novartis, alongside a growing ecosystem of innovative biotech companies and start-ups.

The programme’s focus on drug discovery, data analytics, precision medicine, clinical research and GMP manufacturing ensures you will develop skills valued across the industry. An eight-month placement further strengthens your workplace readiness and professional networks.

Biotechnology focuses on using living organisms, cells and biological processes to develop products such as medicines, vaccines, diagnostics and biopharmaceuticals.

Therapeutic technologies build on these foundations but take a broader, future-focused approach.

At RCSI, you will explore how emerging technologies such as AI, computational biology, data analytics and precision medicine are transforming healthcare.

The programme also examines advanced treatment approaches including precision medicine, cell therapy, gene therapy and immunotherapy, alongside the processes involved in drug discovery and pharmaceutical development.

This multidisciplinary perspective prepares you to work across science, technology and healthcare innovation in ways that traditional biotechnology programmes may not.

As a student on RCSI’s BSc ATT, you will develop a unique combination of scientific, technical and professional skills designed for the future of healthcare.

The programme covers drug discovery, cell and gene therapy, immunotherapy, precision medicine, pharmaceutical technology, data analytics and computational biology. You will gain practical laboratory and research experience while learning to apply AI, machine learning and digital technologies to healthcare challenges and the analysis of large biological datasets such as genomics and clinical trials data.

In addition, emphasis is placed on developing skills such as communication, teamwork, leadership, innovation and project management.

This blend of technical expertise and professional capability ensures you will thrive in the global biotech and biopharmaceutical industries, as well as related sectors, after graduation.